Investigators at Hunan Cancer Hospital Report Findings in Non-Small Cell Lung Cancer (Neoadjuvant Immunotherapy and Non-small Cell Lung Cancer a Systematic Review and Meta-analysis of Randomized Controlled Trials).

Předmět:	NON-small-cell lung carcinoma PATHOLOGIC complete response MEDICAL research RANDOMIZED controlled trials LUNG diseases IMMUNOTHERAPY
Zdroj:	Immunotherapy Weekly; 11/26/2024, p482-482, 1p
Abstrakt:	A study conducted at Hunan Cancer Hospital in the People's Republic of China evaluated the effectiveness and safety of neoadjuvant immunotherapy for patients with non-small cell lung cancer (NSCLC). The meta-analysis of eleven randomized controlled trials showed that neoadjuvant immunochemotherapy had better clinical efficacy than neoadjuvant chemotherapy for NSCLC patients. The study concluded that the long-term survival outcomes of neoadjuvant immunotherapy need further confirmation to guide clinical practice. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu